RxDoctor Payments Data

Henry Kikunaga

Corneal and Contact Management · Bonita, CANPI 1841406394

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,121 of the $2,583 with a category attached, or 82.1%. Alcon accounts for 61.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,181, 4.3 times the $275 reported in 2019.

$2,583in general payments, 2019–2025

Across 45 payments — averaging $57.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Johnson & Johnson Vision Care, Inc.$363
  • Coopervision Inc.$302
  • Glaukos Corporation$108
  • Tarsus Pharmaceuticals, Inc.$106
  • Biotissue Holdings Inc.$88
  • plus $28 from 1 others

What the payments were for

  • Travel & lodging$46218%
  • Food & beverage$2,12182%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,583 in reported general payments places this provider in the 65th percentile of 140 corneal and contact management providers in California.

See all corneal and contact management providers in California

Medicare billing

Part B allowed, 2024
$6,582
Medicare patients
42
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other corneal and contact management in Bonita

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →